Compounds and methods for antiviral therapy
China Patent
Stats

Importance
| CN Family Size
|
Non-US Coverage
|
Abstract
Compounds and pharmaceutically acceptable salts and esters thereof are provided for the treatment of viral infections. The compounds and compositions are useful for treating pneumovirinae virus infections. The compounds, compositions and methods provided are particularly useful for treating human respiratory syncytial virus infection.
First Claim
Family
- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Country Designations
Patent Owner(s)
| Patent Owner | Address |
|---|---|
| GILEAD SCIENCES INC | USFOSTER CITY CA 94404 |
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Inventor(s)
| Inventor Name | Address |
|---|---|
| PARRISH JAY P | - |
| YANG HAI | C/O GILEAD SCIENCES INC 333 LAKESIDE DRIVE FOSTER CITY CALIFORNIA 94404 US |
| SPERANDIO DAVID | C/O BIOMEA FUSION INC 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CALIFORNIA 94063 US |
| SIEGEL DUSTIN | FOSTER CITY CA 94404 |
| MACKMAN RICHARD L | 360 ASHTON AVENUE MILLBRAE CALIFORNIA 94030 US |
| HUI HON CHUNG | - |
| SANGI MICHAEL | - |
Cited Art Landscape
- No Cited Art to Display
Full Text
Legal Events
Matter Detail
Update Public Data
Dismiss
Edit
Save
Renewals Detail
Edit
Save
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Note
The template below is formatted to ensure compatibility with our system.
Provide tags with | separated like (tags1|tags2).
Maximum length is 128 characters for Customer Application No
Mandatory Fields * - 'MatterType','AppType','Country','Title','SerialNo'.
Acceptable Date Format - 'MM/DD/YYYY'.
Acceptable Filing/App Types -
- Continuation/Divisional
- Original
- Paris Convention
- PCT National
- With Priority
- EP Validation
- Provisional Conversion
- Reissue
- Provisional
- Foreign Extension
Acceptable Status -
- Pending
- Abandoned
- Unfiled
- Expired
- Granted
Acceptable Matter Types -
- Patent
- Utility Model
- Supplemental Protection Certificate
- Design
- Inventor Certificate
- Plant
- Statutory Invention Reg
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Success
E-mail has been sent successfully.
Failure
Some error occured while sending email. Please check e-mail and try again!
Important Notes on Latency of Status data
This Status indicator is an estimation based on the relevant document kind code. As such, it status will only indicate "Published" or "Granted". Expired, lapsed or abandoned statuses are not available in this release. Please refer to the legal status information for more information.
This status should not be taken as legal conclusion. No representations are made as to the accuracy of the status provided. Please consult a legal professional before relying on this status information.
Important Note on Priority Date data
This priority date is an estimated earliest priority date and is purely an estimation. This date should not be taken as legal conclusion. No representations are made as to the accuracy of the date listed. Please consult a legal professional before relying on this date.
Only for Granted EP cases
EP validations represent the countries in which the EP patent may be in force. Data is based on reporting from the various EP contracting states. The reporting consistency can vary across the countries.